Clinical Trials Logo
  1. Home
  2. Acute Exacerbation of COPD
  3. NCT03255057

Extracorporeal CO2 Removal With the Hemolung RAS for Mechanical Ventilation Avoidance During Acute Exacerbation of COPD — VENT-AVOID  

Acute Exacerbation of COPD Clinical Trial

Official title:
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support

Clinical Trial Summary

This study evaluates the safety and efficacy of using the Hemolung RAS to provide low-flow extracorporeal carbon dioxide removal (ECCO2R) as an alternative or adjunct to invasive mechanical ventilation for patients who require respiratory support due to an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD). It is hypothesized that the Hemolung RAS can be safely used to avoid or reduce time on invasive mechanical ventilation compared to COPD patients treated with standard-of-care mechanical ventilation alone. Eligible patients will be randomized to receive lung support with either the Hemolung RAS plus standard-of-care mechanical ventilation, or standard-of-care mechanical ventilation alone.

Clinical Trial Description

The Hemolung RAS provides low-flow ECCO2R using a single, 15.5 French dual-lumen catheter inserted percutaneously in the femoral or jugular vein. Low-flow ECCO2R offers an alternative or supplement to invasive mechanical ventilation (MV) for patients suffering from acute, reversible, hypercapnic respiratory failure. In contrast to invasive MV, low-flow ECCO2R provides partial ventilatory support independently of the lungs. The rationale for this study is that low-flow ECCO2R with the Hemolung RAS can be used to provide supplemental CO2 removal in COPD patients experiencing acute hypercapnic respiratory failure to either avoid or reduce time on invasive MV. In this patient population, avoidance or reduced time on invasive MV may have significant clinical benefit in reducing the many complications associated with invasive MV. The major complication risks of low-flow ECCO2R are associated with central venous catheterization and the need for anticoagulation during treatment. This study is designed to evaluate the safety and efficacy of Hemolung RAS plus standard-of-care as compared to standard-of-care alone. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03255057
Study type Interventional
Source Alung Technologies
Contact
Status Terminated
Phase N/A
Start date February 18, 2018
Completion date August 17, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04098094 - Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
Not yet recruiting NCT05286918 - Antibiotic Stewardship in AECOPD Through CRP-Guided Management N/A
Not yet recruiting NCT05019911 - Prediction of Exacerbations and Management of COPD Patients With SAH Based on Millimeter Wave Radar Monitoring
Not yet recruiting NCT05539547 - Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD Early Phase 1
Recruiting NCT06014034 - Randomized Controlled Study of Programmed Weaning From Noninvasive Mechanical Ventilation for Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A
Not yet recruiting NCT06084117 - High Flow Nasal Oxygen for Exacerbation COPD N/A
Not yet recruiting NCT05059873 - Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels Phase 4
Recruiting NCT04640948 - High VS Low Flow Nasal O2 for Acute Hypercapnic Respiratory Failure N/A
Recruiting NCT04448236 - Effect of Blood Flow Restriction Resistance Exercises in COPDAE In-patient Rehabilitation N/A
Recruiting NCT05480566 - Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD N/A
Completed NCT05504993 - Are Comorbidities Related to Frequent Severe Exacerbations of AECOPD
Completed NCT03077152 - Patient Factors Associated With Prescription of Antibiotics for Inappropriate Indication in Patients With AECOPD
Not yet recruiting NCT04147104 - ecco2R to facilitatE earLy libEration From mechanicAl Ventilation inpatientS With Copd Acute Exacerbation N/A
Not yet recruiting NCT05209607 - Social Media-based Bundle Care of AECOPD Patients. Phase 4
Recruiting NCT04538976 - Copd Exacerbation and Pulmonary Hypertension Trial Phase 4
Recruiting NCT05280132 - Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial N/A
Completed NCT04414891 - Non Invasive Ventilation With NAVA vs ASV for AECOPD N/A
Completed NCT05563493 - Effects of Chair-Based Exercise Training on Exercise Capacity in Patients With Acute Exacerbation of COPD N/A
Recruiting NCT04843696 - Negative Pressure Ventilation-rehabilitation on Acute Exacerbation of Chronic Obstructive Pulmonary Disease N/A